vTv Therapeutics Inc. - Class A Common Stock — Liquidità Trimestrale (NASDAQ:VTVT)

Financials

Totale attivo 38.27 M32.03 M26.45 M99.49 M89.9 M98.81 M Totale passività 23.96 M23.13 M24.04 M28.95 M25.46 M8.85 M Patrimonio netto totale 14.3 M8.9 M2.4 M70.54 M64.44 M89.96 M Totale passività e patrimonio netto 38.27 M32.03 M26.45 M99.49 M89.9 M98.81 M Debito totale 0————— Indebitamento netto -36.75 M—————

Notizie

vTv Therapeutics (VTVT) is on the Move, Here's Why the Trend Could be Sustainable

H.C. Wainwright abbassa il target su vTv Therapeutics a $45

Wall Street Analysts See a 39.9% Upside in vTv Therapeutics (VTVT): Can the Stock Really Move This High?

BTIG conferma Buy su vTv Therapeutics, target a 49$

Evercore ISI avvia la copertura su vTv Therapeutics con rating outperform

Evercore ISI initiates vTv Therapeutics stock with outperform rating

BTIG conferma Buy su vTv Therapeutics, target di 49$ mantenuto

BTIG reiterates Buy on vTv Therapeutics stock, $49 target maintained

VTv Stock: Cadisegliatin's Phase 3 CATT1 Readout Is The Next Catalyst (NASDAQ:VTVT)

vTv Therapeutics espande l’accordo di licenza per HPP737 con Newsoara Biopharma

vTv Therapeutics expands HPP737 license agreement with Newsoara Biopharma

vTv expands Newsoara license deal for PDE4 inhibitor to global rights